Rachel Offenbacher
Overview
Explore the profile of Rachel Offenbacher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tal A, Gunawardana-Zeigler S, Peng D, Tan Y, Munoz Perez N, Offenbacher R, et al.
Mol Cancer Ther
. 2025 Jan;
PMID: 39781890
Osteosarcoma (OS) is the most common primary malignant bone tumor in childhood. Patients who present with metastatic disease at diagnosis or relapse have a very poor prognosis, and this has...
2.
Tal A, Gunawardana-Zeigler S, Peng D, Tan Y, Munoz Perez N, Offenbacher R, et al.
bioRxiv
. 2024 Dec;
PMID: 39713389
Osteosarcoma (OS) is the most common primary malignant bone tumor in childhood. Patients who present with metastatic disease at diagnosis or relapse have a very poor prognosis, and this has...
3.
Offenbacher R, Kaswan S, Fabish L, Barron C, Fox J, Chin S, et al.
J Pediatr Hematol Oncol
. 2024 Sep;
46(8):433-437.
PMID: 39269157
Background: Sclerosing epithelioid fibrosarcoma (SEF) is a very rare soft tissue sarcoma that most commonly presents in middle-aged and elderly adults but has been rarely seen in children. SEF is...
4.
Davitt M, Offenbacher R, Lee M, Loeb D, Manwani D, Mitchell W, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(9):e31175.
PMID: 38961591
Atypical hemolytic uremic syndrome (aHUS) is a complement-mediated thrombotic microangiopathy sometimes associated with germline variants in genes of the complement system. Clinical findings of microangiopathic hemolytic anemia, thrombocytopenia, and acute...
5.
Offenbacher R, Jackson K, Hayashi M, Zhang J, Peng D, Tan Y, et al.
bioRxiv
. 2024 Jul;
PMID: 38948823
Polyamine metabolism and signaling play important roles in multiple cancers but have not previously been studied in Ewing sarcoma. Here, we show that blocking polyamine synthesis with D, L-alpha-difluoromethylornithine (DFMO)...
6.
Offenbacher R, Citron C, Lin J, Hosgood H, Parsons S, Moerdler S, et al.
JCO Oncol Pract
. 2024 Jun;
21(2):155-161.
PMID: 38917405
Purpose: Sepsis is the leading cause of mortality in patients with childhood cancer receiving cytotoxic chemotherapy. Pediatric hematology/oncology and transplant (PHOT) providers must counsel their patients on the safety of...
7.
Offenbacher R, Norris S, Loeb D, Levy A
J Adolesc Young Adult Oncol
. 2023 Oct;
13(2):361-363.
PMID: 37870570
Adolescent and young adults (AYAs) require support from their parents and caregivers. While there are formal programs available for patients with complex medical problems, <20% of pediatric practices are performing...
8.
Offenbacher R, Briggs J, Ronca K, Uong A, Ogidan-Odeseye O, Kim M, et al.
Pediatr Blood Cancer
. 2022 Oct;
70(1):e30045.
PMID: 36215215
Purpose: We sought to improve caregiver retention of critical initial hospital discharge instructions using a multidisciplinary, team-based intervention for newly diagnosed pediatric cancer patients at high risk for unfavorable outcomes....
9.
Offenbacher R, Gorlick J, Weiser D
Cancer Rep (Hoboken)
. 2022 Oct;
5(11):e1724.
PMID: 36199156
Background: Children receiving cytotoxic therapy for cancer have increased risk of infection due to drug-induced neutropenia and are therefore treated empirically for bacteremia when febrile or ill-appearing. However, viral infections,...
10.
Offenbacher R, Kobets A, Dalvi N, Hsu K, Chin S, Snuderl M, et al.
Childs Nerv Syst
. 2022 Sep;
39(3):801-805.
PMID: 36107222
Introduction: Pilocytic astrocytoma, a World Health Organization grade 1 tumor, is the most common brain tumor in children between 5 and 14 years of age and the second most common...